Home
My Account
About Us
Forum
Contact us
الواجهة العربية
epharmaweb.com
Medical News Medical News
Aricles Articles
Events Events
Guidelines Guidelines
Videos Library Videos Library
Diseases Diseases
Follow us : facebook twitter Digg Linkedin Boxiz
Newsletter

Please select the categories you are intersted in:
News Articles Guidelines Events Videos Journals' abstracts

Latest Subscribers
Advanced Search »



Researchers Develop a Potential Vaccine Alzheimer's Disease


Researchers Develop a Potential Vaccine Alzheimer's Disease

(epharmanews)- Alzheimer’s disease has been the subject of many research and studies trying to find a successful treatment or a least decrease the risk to developing it. Recently, coffee was found to significantly decrease the risk to develop Alzheimer’s disease. However, this new discovery might put an end to the prevalence of this disease.

Scientists’ efforts to stop Alzheimer’s disease are the result of an increasing fear from this progressive disease that can be found in 5.3 million patients today and it is estimated that a 100 million people will develop this disease by 2050.

Alzheimer’s disease is the main risk factor for developing dementia, which is considered as the fastest epidemic nowadays according to WHO. Alzheimer’s disease results from the accumulation of amyloids on the nerve cells which eventually destroy them.

Researchers at the Karolinska Institutet, Sweden, tested a new vaccine known as “CAD106” which provides an active, effective immunity designed to direct the human immune system to defend the body against amyloids accumulated in the brain.

After three years of experiments, researchers found that 80% of treated patients developed their own antibodies to target the amyloids. What really surprised the researchers was the fact that this vaccine had no side effects.

The results of this study are published in the Lancet Neurology.

The researchers believe that this suggests that the CAD106 vaccine is a tolerable treatment for patients with mild to moderate Alzheimer's. Larger trials must now be conducted to confirm the CAD106 vaccine's efficacy.


اضغط هنا للقراءة باللغة العربية

Prepared by: Abdullatief Janat


Source :

ePharmaNews






Other Comments

Add a comment

You must sign in to use this servcie

Username:
Password:


facebook comments

Forgot your password


sign up

Consultants Corner

Dr . Dirar Abboud

Dr . Dirar Abboud Hepatologist – Gastroenterologist

Dr. Samer Al-Jneidy

Dr. Samer Al-Jneidy Pediatrician

Yaser Habrawi , F.R.C.S.Ed

Yaser Habrawi , F.R.C.S.Ed Consultant Ophthalmologist

Samir Moussa M.D.

Samir Moussa M.D. ENT Specialist

Dr. Faisal Dibsi

Dr. Faisal Dibsi Specialist of Otolaryngology - Head and Neck Surgery

Dr. Tahsin Martini

Dr. Tahsin Martini Degree status: M.D. in Ophthalmology

Dr. Hani Najjar

Dr. Hani Najjar Pediatrics, Neurology

Dr. Talal Sabouni

Dr. Talal Sabouni UROLOGY AND KIDNEY TRANSPLANT
Poll

Which of the following you are mostly interested in?

Cancer Research
Mental Health
Heart Disease & Diabetes
Sexual Health
Obesity and Healthy Diets
Mother & Child Health

Disclaimer : This site does not endorse or recommend any medical treatment, pharmaceuticals or brand names. More Details